Phase 4 Ankylosing Spondylitis Trial, Recruiting (NCT06112665)

Phase 4 Ankylosing Spondylitis Trial, Recruiting NCT06112665 Sponsor: Charite University, Berlin, Germany Condition: Ankylosing Spondylitis

Printed from Voxsanity (voxsanity.com.au) — NCT06112665 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ankylosing Spondylitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a condition called axial spondyloarthritis (axSpA) and meet the standard classification guidelines for this condition.
You have had back pain symptoms for 2 years or less, fitting the definition of "early" axial spondyloarthritis.
Your disease is currently active, meaning your back pain and disease activity scores are above a certain level (as measured by a standard questionnaire called BASDAI), AND there are signs of inflammation visible on an MRI scan of your lower back/pelvis joints AND/OR your blood tests show raised inflammation levels.

Who may not be able to join:

You currently have an active infection, or you have had a serious infection within the last 3 months.
You have a history of repeated Herpes zoster (shingles) infections or a severe widespread Herpes simplex infection.
You have a condition that weakens your immune system.
You have a long-term (chronic) Hepatitis B, Hepatitis C, or HIV infection.
You are pregnant or currently breastfeeding, or you are a woman who is not willing or able to use a reliable form of contraception during the trial.
You have another serious illness that could interfere with taking part in a clinical study, or you have a reason why you cannot have an MRI scan (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Denis Poddubbnyy, Prof. Dr. med., Charité Rheumatology

Phone: +49308445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06112665

Sponsor: Charite University, Berlin, Germany

Phase: Phase 4

Status: Recruiting

Condition: Ankylosing Spondylitis

Trial contact: +49308445

More information: https://clinicaltrials.gov/study/NCT06112665

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a condition called axial spondyloarthritis (axSpA) and meet the standard classification guidelines for this condition.
You have had back pain symptoms for 2 years or less, fitting the definition of "early" axial spondyloarthritis.
Your disease is currently active, meaning your back pain and disease activity scores are above a certain level (as measured by a standard questionnaire called BASDAI), AND there are signs of inflammation visible on an MRI scan of your lower back/pelvis joints AND/OR your blood tests show raised inflammation levels.

Who may not be able to join:

You currently have an active infection, or you have had a serious infection within the last 3 months.
You have a history of repeated Herpes zoster (shingles) infections or a severe widespread Herpes simplex infection.
You have a condition that weakens your immune system.
You have a long-term (chronic) Hepatitis B, Hepatitis C, or HIV infection.
You are pregnant or currently breastfeeding, or you are a woman who is not willing or able to use a reliable form of contraception during the trial.
You have another serious illness that could interfere with taking part in a clinical study, or you have a reason why you cannot have an MRI scan (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

10 November 2023

Est. completion

1 March 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Main trial endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov